// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























4759 Abstracts

Effect of Dexmedetomidine on Glycemic and Insulin Levels in the Perioperative Period of Obese Insulin Resistent Patients

Eduardo A. Vega Perez - American Society of Anesthesiologists (ASA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Dexmedetomidine hydrochloride

Hemoglobin-A1c level to predict for clinical outcomes in patients with pancreatic cancer.

Katherine Y. Fan - American Society of Clinical Oncology (ASCO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

Metabolic syndrome and breast cancer: Effects of a 16-week combined exercise intervention.

Christina Marie Dieli-Conwright - American Society of Clinical Oncology (ASCO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metabolic syndrome

N/A

Changes in glucose, insulin, and insulin resistance from presurgery to post adjuvant treatment for breast cancer.

Emer M. Guinan - American Society of Clinical Oncology (ASCO) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Changes in body fat and lipid metabolism in testicular cancer patients undergoing curative chemotherapy.

Peter-Paul Michiel Willemse - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Testicular cancer

Cisplatin

EFFECTS OF AEROBIC EXERCISE ON COGNITION AND BIOMARKERS IN ADULTS WITH A DOUBLE-HIT RISK FOR DEMENTIA: MILD COGNITIVE IMPAIRMENT AND PREDIABETES

Laura D. Baker - Alzheimer's Association International Conference (AAIC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Mild cognitive impairment

N/A

IMPACT OF GLUCOSE LEVELS ON MEMORY FUNCTIONS AND HIPPOCAMPAL MICROSTRUCTURE IN OLDER ADULTS

Agnes Floeel - Alzheimer's Association International Conference (AAIC) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

DIABETES AND ALZHEIMER-S-ASSOCIATED GENES AFFECT DIFFERENTLY THE ASSOCIATION OF GLYCEMIC CONTROL WITH COGNITIVE FUNCTION

Michal Schnaider Beeri - Alzheimer's Association International Conference (AAIC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Alzheimer's disease

N/A

ELEMENTS OF METABOLIC SYNDROME IN AN URBAN SAMPLE WITH MILD COGNITIVE IMPAIRMENT

Karen Benabou - Alzheimer's Association International Conference (AAIC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Mild cognitive impairment

N/A

IMPACT OF DEMENTIA ON DIABETES CARE QUALITY IN ONTARIO

Yelena Petrosyan - Alzheimer's Association International Conference (AAIC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Dementia

N/A

DIABETES AND COGNITIVE FUNCTIONING AMONG DEMENTIA-FREE ELDERLY PEOPLE: ROLE OF GLYCEMIC CONTROL AND APOE 4 ALLELE

Anna Marseglia - Alzheimer's Association International Conference (AAIC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Salcaprozate sodium

PLASMA AMYLIN LEVELS ARE ASSOCIATED WITH BRAIN STRUCTURE AMONG INDIVIDUALS WITH TYPE-2 DIABETES

Timothy M. Hughes - Alzheimer's Association International Conference (AAIC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

RELATIONSHIP BETWEEN GLYCAEMIC CONTROL AND COGNITIVE FUNCTION IN PATIENTS WITH TYPE 2 DIABETES AT ELEVATED CARDIOVASCULAR RISK

Jolien Janssen - Alzheimer's Association International Conference (AAIC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Glimepiride

Outcome of Japanese Minor Stroke Patients Treated Without Intravenous Recombinant Tissue Plasminogen Activator Within 4.5 Hours After the Symptom Onset ~Fukuoka Stroke Registry~

Shigeru Fujimoto - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

AFRICAN BITER KOLA SEED AND ITS POTENTIAL THERAPEUTIC EFFECTS IN HYPERGLYCAEMIA AND HYPERLIPIDAEMIA IN THE BLOOD OF DIABETIC RATS

O. Ayepola - European Atherosclerosis Society (EAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Superoxide dismutase

LOW-LDL-CHOLESTEROL IN DIABETIC PATIENTS WITHOUT LIPID-LOWERING THERAPY. HOW MANY OF THESE PATIENTS SHOULD TAKE STATINS ACCORDING TO STANDARDS OF MEDICAL CARE IN DIABETES?

J. Rodriguez-Encinar - European Atherosclerosis Society (EAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

IMPROVED HEALTH OUTCOMES BY INDENTIFYING HIGH CARDIOVASCULAR RISK INDIVIDUALS IN A PHARMACY SETTING- A RANDOMIZED CONTROLLED TRIAL

V. Telle-Hansen - European Atherosclerosis Society (EAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

AGE-, SEX- AND GLUCOSE-DEPENDENT CORRELATION OF PLASMA SOLUBLE VASCULAR ADHESION PROTEIN-1 CONCENTRATION WITH CARDIOVASCULAR RISK FACTORS AND SUBCLINICAL ATHEROSCLEROSIS

R. Zhao - European Atherosclerosis Society (EAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Alora

PREDIABETES AND DIABETES ARE NOT RELATED TO ENDOTHELIAL DYSFUNCTION AMONG PATIENTS WITH UNSTABLE CORONARY SYNDROMES.

E.S. Oskarsdottir - European Atherosclerosis Society (EAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vasodilation dysfunction

N/A

PULSE WAVE VELOCITY AND ABNORMAL AUGMENTATION INDEX IN THE SHOWCASE OF VASCULAR SENESCENCE.

S. Tello-Blasco - European Atherosclerosis Society (EAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hyperglycemia

N/A

Copyright © 2026. QuantiNova All rights reserved